Literature DB >> 28089822

MicroRNAs in pituitary tumors.

Anne Wierinckx1, Magali Roche2, Catherine Legras-Lachuer3, Jacqueline Trouillas4, Gérald Raverot5, Joël Lachuer6.   

Abstract

Since the presence of microRNAs was first observed in normal pituitary, the majority of scientific publications addressing their role and the function of microRNAs in the pituitary have been based on pituitary tumor studies. In this review, we briefly describe the involvement of microRNAs in the synthesis of pituitary hormones and we present a comprehensive inventory of microRNA suppressors and inducers of pituitary tumors. Finally, we summarize the functional role of microRNAs in tumorigenesis, progression and aggressiveness of pituitary tumors, mechanisms contributing to the regulation (transcription factors, genomic modifications or epigenetic) or modulation (pharmacological treatment) of microRNAs in these tumors, and the interest of thoroughly studying the expression of miRNAs in body fluids.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Pituitary tumors; microRNAs

Mesh:

Substances:

Year:  2017        PMID: 28089822     DOI: 10.1016/j.mce.2017.01.021

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  18 in total

Review 1.  Prognostic factors of regrowth in nonfunctioning pituitary tumors.

Authors:  Gerald Raverot; Alexandre Vasiljevic; Emmanuel Jouanneau
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

Review 2.  Recent Understanding and Future Directions of Recurrent Corticotroph Tumors.

Authors:  José Miguel Hinojosa-Amaya; César Ernesto Lam-Chung; Daniel Cuevas-Ramos
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-26       Impact factor: 5.555

3.  Identification and characterization of microRNAs in the pituitary of pubescent goats.

Authors:  Jing Ye; Zhiqiu Yao; Wenyu Si; Xiaoxiao Gao; Chen Yang; Ya Liu; Jianping Ding; Weiping Huang; Fugui Fang; Jie Zhou
Journal:  Reprod Biol Endocrinol       Date:  2018-05-25       Impact factor: 5.211

4.  Increased E2F1 mRNA and miR-17-5p Expression Is Correlated to Invasiveness and Proliferation of Pituitary Neuroendocrine Tumours.

Authors:  Araceli García-Martínez; Beatriz López-Muñoz; Carmen Fajardo; Rosa Cámara; Cristina Lamas; Sandra Silva-Ortega; Ignacio Aranda; Antonio Picó
Journal:  Diagnostics (Basel)       Date:  2020-04-16

5.  Circulating Plasma microRNA to Differentiate Cushing's Disease From Ectopic ACTH Syndrome.

Authors:  Zhanna Belaya; Patimat Khandaeva; Larisa Nonn; Alexey Nikitin; Alexander Solodovnikov; Ivan Sitkin; Andrey Grigoriev; Mikhail Pikunov; Anastasia Lapshina; Liudmila Rozhinskaya; Galina Melnichenko; Ivan Dedov
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-05       Impact factor: 5.555

6.  MicroRNA-186 targets SKP2 to induce p27Kip1-mediated pituitary tumor cell cycle deregulation and modulate cell proliferation.

Authors:  Zongze He; Longyi Chen; Qi Wang; Cheng Yin; Junting Hu; Xiao Hu; Fan Fei; Jian Tang
Journal:  Korean J Physiol Pharmacol       Date:  2019-04-24       Impact factor: 2.016

7.  Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke's cell morphology.

Authors:  Filip Garbicz; Dawid Mehlich; Beata Rak; Emir Sajjad; Maria Maksymowicz; Wiktor Paskal; Grzegorz Zieliński; Paweł K Włodarski
Journal:  Pituitary       Date:  2017-08       Impact factor: 4.107

Review 8.  Pituitary-Directed Therapies for Cushing's Disease.

Authors:  Fabienne Langlois; Jennifer Chu; Maria Fleseriu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-01       Impact factor: 5.555

Review 9.  Recent advances in understanding corticotroph pituitary tumor initiation and progression.

Authors:  Ulrich Renner; Denis Ciato; Günter K Stalla
Journal:  F1000Res       Date:  2018-08-29

10.  MiR-15a/miR-16-1 expression inversely correlates with cyclin D1 levels in Men1 pituitary NETs.

Authors:  Kate E Lines; Paul J Newey; Christopher J Yates; Mark Stevenson; Rebecca Dyar; Gerard V Walls; Mike R Bowl; Rajesh V Thakker
Journal:  J Endocrinol       Date:  2018-09-01       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.